Important update from the GAIA CLL13 Trial com... - CLL Support
Important update from the GAIA CLL13 Trial comparing venetoclax combinations with chemoimmunotherapy for first-line CLL
You need to be a member of this community to see this post.
Read more about...
7 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Venetoclax plus obinutuzumab - the first chemotherapy-free, fixed-duration first line CLL treatment approved by Health Canada
and higher rates of undetectable minimal
residual disease compared to patients receiving a...
UK NICE Approves Ibrutinib +Venetoclax for First Line treatment for ALL Patients from today
fludarabine, cyclophosphamide and rituximab (FCR) or venetoclax plus obinutuzumab via the Cancer...
Finishing line for Pirtobrutinib (Loxo) & Venetoclax combination trial.
completed the 2 year combination clinical trial with Pirtobrutinib and Venetoclax - I think a small...
B-PLL: Ibrutrinib Monotherapy or Obinutuzumab (aka Gazyva) & Venetoclax Combination as first-line treatment for transformed CLL
1) Monotherapy Ibrutinib or Acalabrutinib
2) Combination therapy Gazyva and Venetoclax
We know...
Chemo-Free Treatment Best Option for CLL Patients Under 70
immunotherapy (chemoimmunotherapy) grouping of fludarabine, cyclophosphamide, and rituximab, known...
Related Posts
- Updated Results: Combined Ibrutinib and Venetoclax for 1st lineTreatment for CLL
AbbVie Pharm--positive phase 3 for CLL!- Health Canada approves Ibrutinib plus Rituximab for First Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
Australian trials ongoing combining Ibrutinib and Venetoclax?- Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL
